Abstract:BACKGROUND:To investigate the protective efficacy of miR-155 on down regulating NADPH oxidase isoform subunit A1 (NoxA1) gene expression, resulting in inhibition of VSMC migration and over proliferation and thus ameliorating the progression of arterial atherosclerosis in AS mouse model. Therefore, to further explore the regulatory effect of miR-155 on neointima formation in AS and locate potential anti-atherosclerosis target.METHODS:The mouse vascular aorta smooth muscle cell (MOVAS) was cultured and transfected with recombinant Pad2YFG adenovirus fluorescent vector with miR-155 fragment into 4 groups. Western blotting and RT-PCR were performed to identify the expression of NoxA1 under different circumstances. Fluorescence microscope was applied to observe the transfection rate of miR-155 into adenovirus. Twelve-week fatty food induced atherosclerotic ApoE-/- mouse model was established as host to accept miR-155 transfected adenovirus transplantation to observe its effect on VSMC in AS progression. Carotid and thoracic artery were extracted at 1 month after dosing. Distribution of miR-155 was quantified via expression levels of protein and RNA to detect NoxA1, Nox1, p47phox and NADPH expression. Immunohistochemistry, fluorescence imaging and other methods were performed in arteries section to compare the thickness of neointima and assess the severity of AS in each group.RESULTS:Luciferase reporter gene assay showed significant expression of miR-155 in mimic group indicating that miR-155 had target binding effect with NoxA1 gene. Western blotting and RT-PCR results both showed significantly decreased NoxA1 expression in miR-155 mimic group while increased with its inhibitor. The miR-155 distribution was observed varied at 1 month after in control, miR-155 mimic and inhibitor groups. The NoxA1, NADPH, Nox1 and pp47phox protein expression in VSMC was decreased in mimic group vs control and inhibitor groups (P<0.05); no significant difference of NADPH expression was observed in all groups. The NoxA1, Nox1 and p47phox gene expression in VSMC were both found reduced compared with those of control group at week 4 (P<0.05). Immunohistochemistry staining of artery frozen sections figured out that the thickness of neointima of carotid artery in miR-155 mimic group was significantly lower vs control and inhibitor groups (P<0.01) at week 4.CONCLUSIONS:miR-155 played an important role in NoxA1-related signaling pathway. miR-155 transfection into VSMC may have anti-inflammatory regulatory effect on NoxA1 expression in vivo and resulting in amelioration of atherosclerotic lesion in AS mouse model. In summary, miR-155 specifically plays in a negative feedback loop and demonstrates a protective role during atherosclerosis-associated VSMC proliferation and neointima formation through the miR-155-NoxA1-p47phox complex signaling pathway.

Creg Reduces Atherosclerosis in Apolipoprotein Deficient Mice

Cellular Repressor of E1a-Stimulated Genes Inhibits Inflammation to Decrease Atherosclerosis in Apoe(-/-) Mice

Overexpression of CREG Attenuates Atherosclerotic Endothelium Apoptosis Via VEGF/PI3K/AKT Pathway.

Cellular Repressor of E1A-stimulated Genes, A New Potential Therapeutic Target for Atherosclerosis.

Expression of Cellular Repressor of E1A-stimulated Genes in Atherosclerotic Artery

Cellular Repressor of E1A-stimulated Genes Inhibits Human Vascular Smooth Muscle Cell Apoptosis Via Blocking P38/JNK MAP Kinase Activation.

Cellular repressor of E1A-stimulated genes attenuates cardiac hypertrophy and fibrosis.

CREG Promotes a Mature Smooth Muscle Cell Phenotype and Reduces Neointimal Formation in Balloon-Injured Rat Carotid Artery

ASSA13-10-13 Cellular Repressor E1A-Stimulated Genes Controls Phenotypic Switching of Adventitial Fibroblasts by Blocking P38mapk Activation

Cellular Repressor of E1A-Stimulated Genes is a Critical Determinant of Vascular Remodeling in Response to Angiotensin II

CREG: a possible candidate for both prevention and treatment of proliferative vascular disease.

[Over-Expression of the Cellular Repressor of E1A-stimulated Genes Inhibits the Apoptosis of Human Vascular Smooth Muscle Cells in Vitro.].

Cellular Repressor E1A-stimulated Genes Controls Phenotypic Switching of Adventitial Fibroblasts by Blocking P38mapk Activation.

CREG Protects from Myocardial Ischemia/reperfusion Injury by Regulating Myocardial Autophagy and Apoptosis.

CREG mediated adventitial fibroblast phenotype modulation: a possible therapeutic target for proliferative vascular disease.

Cellular repressor of E1A stimulated genes enhances endothelial monolayer integrity

CREG inhibits migration of human vascular smooth muscle cells by mediating IGF-II endocytosis.

DNA Hypermethylation: A Novel Mechanism of CREG Gene Suppression and Atherosclerogenic Endothelial Dysfunction.

ASSA13-10-14 Cellular Repressor of E1A-Stimulated Genes Accelerates Endothelial Angiogenesis Via Integrin-Linked Kinase-PINCH-CDC42 Activation

Protection of Cellular Repressor of E1A Stimulated Genes Against TNF-α-Mediated Inflammatory Injury of Vascular Endothelial Cells

MiR-155 Acts As an Inhibitory Factor in Atherosclerosis-Associated Arterial Pathogenesis by Down-Regulating NoxA1 Related Signaling Pathway in ApoE-/- Mouse.